Last week’s MM&M webcast titled “From Selling Pills to Selling Health Outcomes” was packed with thought provoking material. Joining the podcast were Daniel Hawkins (Clarion Healthcare Consulting), Dennis Urbaniak (Sanofi-Aventis) and Dan Rubin (inVentiv Patient …
Read the full story »
You can’t imagine our surprise today when we saw that Pfizer has announced that it will license injectable and solid dosage forms from Aurobindo. We wrote about Pfizer’s new generics strategy on monday, but we …
Although we’ve seen a huge increase in the number of clients going straight to purchasing white-label formulations products, basically the switch for European generics companies from manufacturing to marketing, CEE markets still have low manufacturing …
![Big pharma grows a [heart] ?](http://www.alensagenerics.com/wp-content/themes/arthemia-premium/scripts/timthumb.php?src=http://www.alensagenerics.com/wp-content/uploads/2009/02/heart-in-hands-300x295.jpg&w=80&h=80&zc=1&q=100)
